Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants

Infection, Genetics and Evolution

Volumn 43, Issue , 2016, Pages 197-202

  Di Gregorio, Sabrina ^a   Fernandez, Silvina ^a   Perazzi, Beatriz ^b   Bello, Natalia ^b   Famiglietti, Angela ^b   Mollerach, Marta ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

HVISA VISA; IS256 transposition; S. aureus

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; PHOSPHATASE; SIGB PROTEIN, BACTERIA; SIGMA FACTOR; TRANSPOSON;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC SENSITIVITY; ARTHROTOMY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM MUTANT; BONE INFECTION; CASE REPORT; CONTROLLED STUDY; DNA TRANSPOSITION; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; GENE INSERTION SEQUENCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTIOUS ARTHRITIS; IS256 TRANSPOSITION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SOUTHERN BLOTTING; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BIOFILM; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSPOSON;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BIOFILMS; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PHOSPHORIC MONOESTER HYDROLASES; SIGMA FACTOR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84971242734     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2016.05.001     Document Type: Article

References (47)

1. Adhikari R.P., Scales G.C., Kobayashi K., Smith J.M., Berger-Bachi B., Cook G.M. Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus. J. Antimicrob. Chemother. 2004, 54:360-363.
2. Andersson D.I., Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 2014, 12:465-478.
3. Benson M.A., Ohneck E.A., Ryan C., Alonzo F., Smith H., Narechania A., Kolokotronis S.O., Satola S.W., Uhlemann A.C., Sebra R., Deikus G., Shopsin B., Planet P.J., Torres V.J. Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element. Mol. Microbiol. 2014, 93:664-681.
4. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
5. Byrne M.E., Rouch D.A., Skurray R.A. Nucleotide sequence analysis of IS256 from the Staphylococcus aureus gentamicin-tobramycin-kanamycin-resistance transposon Tn4001. Gene 1989, 81:361-367.
6. Chen H.Y., Chen C.C., Fang C.S., Hsieh Y.T., Lin M.H., Shu J.C. Vancomycin activates sigma(B) in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicity. PLoS One 2011, 6.
7. Chung M., de Lencastre H., Matthews P., Tomasz A., Adamsson I., Aires de Sousa M., Camou T., Cocuzza C., Corso A., Couto I., Dominguez A., Gniadkowski M., Goering R., Gomes A., Kikuchi K., Marchese A., Mato R., Melter O., Oliveira D., Palacio R., Sa-Leao R., Santos Sanches I., Song J.H., Tassios P.T., Villari P. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb. Drug Resist. 2000, 6:189-198.
8. CLSI Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A7 2012, Laboratory Standards Institute, Wayne, PA, Clinical and.
9. Cuirolo A., Plata K., Rosato A.E. Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS response. J. Antimicrob. Chemother. 2009, 64:37-45.
10. Di Rienzo J.A.C.F., Balzarini M.G., Gonzalez L., Tablada M., Robledo C.W. InfoStat versión 2013, 2013. http://www.infostat.com.ar.
11. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 2000, 38:1008-1015.
12. Galbusera E., Renzoni A., Andrey D.O., Monod A., Barras C., Tortora P., Polissi A., Kelley W.L. Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance. Antimicrob. Agents Chemother. 2011, 55:1008-1020.
13. Gardella N., Picasso R., Predari S.C., Lasala M., Foccoli M., Benchetrit G., Famiglietti A., Catalano M., Mollerach M., Gutkind G. Methicillin-resistant Staphylococcus aureus strains in Buenos Aires teaching hospitals: replacement of the multidrug resistant South American clone by another susceptible to rifampin, minocycline and trimethoprim-sulfamethoxazole. Rev. Argent. Microbiol. 2005, 37:156-160.
14. Gardella N., von Specht M., Cuirolo A., Rosato A., Gutkind G., Mollerach M. Community-associated methicillin-resistant Staphylococcus aureus, eastern Argentina. Diagn. Microbiol. Infect. Dis. 2008, 62:343-347.
15. Gilot P., Lina G., Cochard T., Poutrel B. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis. J. Clin. Microbiol. 2002, 40:4060-4067.
16. Harmsen D., Claus H., Witte W., Rothganger J., Turnwald D., Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 2003, 41:5442-5448.
17. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8:R19.
18. Heusser R., Ender M., Berger-Bachi B., McCallum N. Mosaic staphylococcal cassette chromosome mec containing two recombinase loci and a new mec complex, B2. Antimicrob. Agents Chemother. 2007, 51:390-393.
19. Howden B.P., Stinear T.P., Allen D.L., Johnson P.D., Ward P.B., Davies J.K. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob. Agents Chemother. 2008, 52:3755-3762.
20. Howden B.P., Davies J.K., Johnson P.D., Stinear T.P., Grayson M.L. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 2010, 23:99-139.
21. Howden B.P., Peleg A.Y., Stinear T.P. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. Infect. Genet. Evol. 2014, 21:575-582.
22. Jansen A., Turck M., Szekat C., Nagel M., Clever I., Bierbaum G. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. Int J Med Microbiol 2007, 297:205-215.
23. Kondo Y., Ito T., Ma X.X., Watanabe S., Kreiswirth B.N., Etienne J., Hiramatsu K. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob. Agents Chemother. 2007, 51:264-274.
24. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., Vandenesch F., Etienne J. Involvement of Panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 1999, 29:1128-1132.
25. Loessner I., Dietrich K., Dittrich D., Hacker J., Ziebuhr W. Transposase-dependent formation of circular IS256 derivatives in Staphylococcus epidermidis and Staphylococcus aureus. J. Bacteriol. 2002, 184:4709-4714.
26. Lyon B.R., Gillespie M.T., Skurray R.A. Detection and characterization of IS256, an insertion sequence in Staphylococcus aureus. J. Gen. Microbiol. 1987, 133:3031-3038.
27. Maki H., McCallum N., Bischoff M., Wada A., Berger-Bachi B. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 2004, 48:1953-1959.
28. Matsuo M., Cui L., Kim J., Hiramatsu K. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3. Antimicrob. Agents Chemother. 2013, 57:5843-5853.
29. McEvoy C.R., Tsuji B., Gao W., Seemann T., Porter J.L., Doig K., Ngo D., Howden B.P., Stinear T.P. Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression. Antimicrob. Agents Chemother. 2013, 57:3240-3249.
30. Milheirico C., Oliveira D.C., de Lencastre H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: 'SCCmec IV multiplex'. J. Antimicrob. Chemother. 2007, 60:42-48.
31. Murakami K., Minamide W., Wada K., Nakamura E., Teraoka H., Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 1991, 29:2240-2244.
32. Nagel M., Reuter T., Jansen A., Szekat C., Bierbaum G. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. Int J Med Microbiol 2011, 301:229-236.
33. O'Neill A.J., Chopra I. Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 2003, 47:1484-1485. (author reply 1485).
34. O'Neill A.J., Cove J.H., Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J. Antimicrob. Chemother. 2001, 47:647-650.
35. Reipert A., Ehlert K., Kast T., Bierbaum G. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob. Agents Chemother. 2003, 47:568-576.
36. Schaaff F., Reipert A., Bierbaum G. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 46:3540-3548.
37. Schreiber F., Szekat C., Josten M., Sahl H.G., Bierbaum G. Antibiotic-induced autoactivation of IS256 in Staphylococcus aureus. Antimicrob. Agents Chemother. 2013, 57:6381-6384.
38. Shoji M., Cui L., Iizuka R., Komoto A., Neoh H.M., Watanabe Y., Hishinuma T., Hiramatsu K. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus. Antimicrob. Agents Chemother. 2011, 55:3870-3881.
39. Shopsin B., Eaton C., Wasserman G.A., Mathema B., Adhikari R.P., Agolory S., Altman D.R., Holzman R.S., Kreiswirth B.N., Novick R.P. Mutations in agr do not persist in natural populations of methicillin-resistant Staphylococcus aureus. J Infect Dis 2010, 202:1593-1599.
40. Sola C., Paganini H., Egea A.L., Moyano A.J., Garnero A., Kevric I., Culasso C., Vindel A., Lopardo H., Bocco J.L. Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean children. PLoS One 2012, 7.
41. Tattevin P., Basuino L., Chambers H.F. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res. Microbiol. 2009, 160:187-192.
42. Traber K.E., Lee E., Benson S., Corrigan R., Cantera M., Shopsin B., Novick R.P. agr function in clinical Staphylococcus aureus isolates. Microbiology 2008, 154:2265-2274.
43. Valihrach L., Demnerova K. Impact of normalization method on experimental outcome using RT-qPCR in Staphylococcus aureus. J. Microbiol. Methods 2012, 90:214-216.
44. Valle J., Vergara-Irigaray M., Merino N., Penades J.R., Lasa I. sigmaB regulates IS256-mediated Staphylococcus aureus biofilm phenotypic variation. J. Bacteriol. 2007, 189:2886-2896.
45. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034 2002.
46. Watanabe Y., Cui L., Katayama Y., Kozue K., Hiramatsu K. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J. Clin. Microbiol. 2011, 49:2680-2684.
47. Wootton M., Howe R.A., Hillman R., Walsh T.R., Bennett P.M., MacGowan A.P. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 2001, 47:399-403.